A Drug-Environment Interaction Between PM2.5 Concentration and Corticosteroid Use on Cardiovascular and Thromboembolic Events in Older Adults - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Interaction of PM2.5 Levels and Corticosteroid Administration on Cardiovascular and Thromboembolic Outcomes in Elderly Individuals

  • By

  • Shu-Ping Huang

  • Chien-Chou Su

  • Rachel Nethery

  • Kevin Josey

  • Benjamin Bates

  • David Robinson

  • Poonam Gandhi

  • Melanie Rua

  • Ashwaghosha Parthasarathi

  • Soko Setoguchi

  • Yea-huei Kao Yang

  • July 1, 2026

Share

Original Source(s)

A Drug-Environment Interaction Between PM2.5 Concentration and Corticosteroid Use on Cardiovascular and Thromboembolic Events in Older Adults

  • by Shu-Ping Huang, Chien-Chou Su, Rachel Nethery, Kevin Josey, Benjamin Bates, David Robinson, Poonam Gandhi, Melanie Rua, Ashwaghosha Parthasarathi, Soko Setoguchi, Yea-huei Kao Yang

  • July 1, 2026

Related Content

Trends and disparities in deaths involving atherosclerotic cardiovascular disease and stroke-related conditions among U.S. adults, 1999–2025

Clinical characteristics and risk factors of atrial fibrillation detection after acute ischemic stroke

Physical activity intensity and cardiovascular disease in Southwest China: a study on data from the China Multi-Ethnic Cohort study